ATS 2018 International Conference - Mobile

David L. Gossage

MD, MBA

Gilead Sciences, Inc.

Session(s)

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial of Presatovir (GS-5806), a ...
Tuesday, May 22 9:15 AM - 9:30 AM